Host antitumour immune responses to HIFU ablation

References

• Hansbrough JF, Bender EM, Zapata-Sirvent R, Anderson J. Altered helper and suppressor lymphocyte populations in surgical patients. Am J Surg 1984; 148: 303–307
   PubMed Web of Science ®Google Scholar
• Mafune K, Tanaka Y. Influence of multimodality therapy on the cellular immunity of patients with esophageal cancer. Ann Surg Oncol 2000; 7: 609–616
   PubMed Web of Science ®Google Scholar
• Vallejo R, Hord ED, Barna SA, Santiago-Palma J, Ahmed S. Perioperative immunosuppression in cancer patients. J Environ Pathol Toxicol Oncol 2003; 22: 139–146
   PubMedGoogle Scholar
• van Sandick JW, Gisbertz SS, ten Berge IJ, Boermeester MA, van der Pouw Kraan TC, Out TA, Obertop H, van Lanschot JJ. Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer. Ann Surg 2003; 237: 35–43
   PubMed Web of Science ®Google Scholar
• Chamberlain SM, Short JH, Nias AH. Recovery of lymphocyte status after radiotherapy. Clin Radiol 1980; 31: 427–432
   PubMed Web of Science ®Google Scholar
• Rotstein S, Blomgren H, Petrini B, Wasserman J, Baral E. Long term effects on the immune system following local radiation therapy for breast cancer. I. Cellular composition of the peripheral blood lymphocyte population. Int J Radiat Oncol Biol Phys 1985; 11: 921–925
   PubMed Web of Science ®Google Scholar
• Shukla HS, Hughes LE, Whitehead RH, Newcombe RG. Long-term follow-up of general immune competence in breast cancer. II. Sequential pre- and post-treatment levels: A 10 year study. Cancer Immunol Immunother 1986; 21: 6–11
   PubMed Web of Science ®Google Scholar
• Toivanen A, Granberg I, Nordman E. Lymphocyte subpopulations in patients with breast cancer after postoperative radiotherapy. Cancer 1984; 54: 2919–2923
   PubMed Web of Science ®Google Scholar
• van Rijswijk RE, Sybesma JP, Kater L. A prospective study of the changes in immune status following radiotherapy for Hodgkin's disease. Cancer 1984; 53: 62–69
   PubMed Web of Science ®Google Scholar
• Dodd GD, III, Soulen MC, Kane RA, Livraghi T, Lees WR, Yamashita Y, Gillams AR, Karahan OI, Rhim H. Minimally invasive treatment of malignant hepatic tumors: At the threshold of a major breakthrough. Radiographics 2000; 20: 9–27
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. Am J Roentgenol 2000; 174: 323–331
   PubMed Web of Science ®Google Scholar
• Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radiofrequency energy. Radiology 2000; 217: 633–646
   PubMed Web of Science ®Google Scholar
• Kennedy JE. High intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 2005; 5: 321–327
   PubMed Web of Science ®Google Scholar
• Wu F. Extracorporeal high intensity focused ultrasound in the treatment of solid malignancies. Minim Invasive Ther Allied Tech 2006; 15: 26–35
   PubMed Web of Science ®Google Scholar
• Bayjoo P, Rees RC, Goepel JR, Jacob G. Natural killer cell activity following cryosurgery of normal and tumour bearing liver in an animal model. J Clin Lab Immunol 1991; 35: 129–132
   PubMedGoogle Scholar
• Miya K, Saji S, Morita T, Niwa H, Sakata K. Experimental study on mechanism of absorption of cryonecrotized tumor antigens. Cryobiology 1987; 24: 135–139
   PubMed Web of Science ®Google Scholar
• Muller LCH, Michsche M, Yamagata S, Kerschbaumer F. Therapeutic effect of cryosurgery of murine osteosarcoma—Influence on disease outcome and immune function. Cryobiology 1985; 22: 77–85
   PubMed Web of Science ®Google Scholar
• Hansler J, Neureiter D, Strobel D, Muller W, Mutter D, Bernatik T, Hahn EG, Becker D. Cellular and vascular reactions in the liver to radio-frequency thermo-ablation with wet needle applicators. Study on juvenile domestic pigs. Eur Surg Res 2002; 34: 357–363
   PubMed Web of Science ®Google Scholar
• Wissniowski TT, Hunsler J, Neureiter D, Frieser M, Schaber S, Esslinger B, Voll R, Strobel D, Hahn EG, Schuppan D. Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res 2003; 63: 6496–6500
   PubMed Web of Science ®Google Scholar
• den Brok MH, Sutmuller RP, van der Voort R, Bennink EJ, Figdor CG, Ruers TJ, Adema GJ. In situ tumor ablation creates an antigen source for the generation of anti-tumor immunity. Cancer Res 2004; 64: 4024–4029
   PubMed Web of Science ®Google Scholar
• Hill CR, Rivens I, Vaughan M, ter Haar GR. Lesion development in focused ultrasound surgery: A general model. Ultrasound Med Biol 1994; 20: 259–269
   PubMed Web of Science ®Google Scholar
• Vaughan M, ter Haar G, Hill CR, Clarke RL, Hopewell JW. Minimally invasive cancer surgery using focused ultrasound: A pre-clinical, normal tissue study. Br J Radiol 1994; 67: 267–274
   PubMed Web of Science ®Google Scholar
• Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu H, Wang ZB. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol 2001; 27: 1099–1106
   PubMed Web of Science ®Google Scholar
• Clement GT. Perspectives in clinical uses of high-intensity focused ultrasound. Ultrasonics 2004; 42: 1087–1093
   PubMed Web of Science ®Google Scholar
• Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu H, Wang ZB. Tumor vessel destruction resulting from high-intensity focused ultrasound in patients with solid malignancies. Ultrasound Med Biol 2002; 28: 535–542
   PubMed Web of Science ®Google Scholar
• Delon-Martin C, Vogt C, Chignier E, Guers C, Chapelon JY, Cathignol D. Venous thrombosis generation by means of high-intensity focused ultrasound. Ultrasound Med Biol 1995; 21: 113–119
   PubMed Web of Science ®Google Scholar
• Rivens IH, Rowland IJ, Denbow M, Fisk NM, ter Haar GR, Leach MO. Vascular occlusion using focused ultrasound surgery for use in fetal medicine. Eur J Ultrasound 1999; 9: 89–97
   PubMedGoogle Scholar
• Hynynen K, Chung A, Colucci V, Jolesz FA. Potential adverse effects of high-intensity focused ultrasound exposure on blood vessels in vivo. Ultrasound Med Biol 1996; 22: 193–201
   PubMed Web of Science ®Google Scholar
• Vaezy S, Martin R, Kaczkowski P, Keilman G, Goldman B, Yaziji H, Carter S, Caps M, Crum L. Use of high-intensity focused ultrasound to control bleeding. J Vasc Surg 1999; 29: 533–542
   PubMed Web of Science ®Google Scholar
• Kennedy JE, ter Haar GR, Wu F, Gleeson FV, Roberts IS, Middleton MR, Cranston D. Contrast-enhanced ultrasound assessment of tissue response to high-intensity focused ultrasound. Ultrasound Med Biol 2004; 30: 851–854
   PubMed Web of Science ®Google Scholar
• Van Leenders GJLH, Beerlage HP, Ruijter ET, de la Rosette JJMCH, van de Kaa CA. Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate. J Clin Pathol 2000; 53: 391–394
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Cao YD, Chen WZ, Zou JZ, Bai J, Zhu H, Li KQ, Jin CB, Xie FL, et al. Changes in biologic characteristics of breast cancer treated with high-intensity focused ultrasound. Ultrasound Med Biol 2003; 29: 1487–1492
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Cao YD, Xu ZL, Zhou Q, Zhu H, Chen WZ. Heat fixation of cancer cells ablated with high intensity focused ultrasound in patients with breast cancer. Am J Surg 2006; 192: 179–184
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Cao YD, Zhou Q, Zhang Y, Zhu XQ. Expression of tumor antigens and heat shock protein 70 in breast cancer cells after high intensity focused ultrasound ablation. Ann Surg Oncol Dec 24, 2007, (PMID: 47187168)
   Web of Science ®Google Scholar
• Chen WR, Zhu W-G, Dynlacht JR, Liu H, Nordquist RE. Long-term tumor resistance induced by laser photo-immunotherapy. Int J Cancer 1999; 81: 808–812
   PubMed Web of Science ®Google Scholar
• Chen WR, Singhal AK, Liu H, Nordquist RE. Laser immunotherapy induced antitumor immunity and its adoptive transfer. Can Res 2001; 61: 459–461
   PubMed Web of Science ®Google Scholar
• Chen WR, Ritchey JW, Bartels KE, Liu H, Nordquist RE. Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats. Can Res 2002; 62: 4295–4299
   PubMed Web of Science ®Google Scholar
• Chen WR, Jeong SW, Lucroy MD, Wolf RF, Howard EW, Liu H, Nordquist RE. Induced anti-tumor immunity against DMBA-4 metastatic mammary tumors in rats using a novel approach. Int J Cancer 2003; 107: 1053–1057
   PubMed Web of Science ®Google Scholar
• Yang R, Reilly CR, Rescorla FJ, Sanghvi NT, Fry FJ, Franklin TD, Grosfeld JL. Effects of high-intensity focused ultrasound in the treatment of experimental neuroblastoma. J Pediatr Surg 1992; 27: 246–251
   PubMed Web of Science ®Google Scholar
• Hu Z, Yang XY, Liu Y, Morse MA, Lyerly HK, Clay TM, Zhong P. Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. Biochem Biophys Res Commun 2005; 335: 124–131
   PubMed Web of Science ®Google Scholar
• Rosberger DF, Coleman DJ, Silverman R, Woods S, Rondeau M, Cunningham-Rundles S. Immunomodulation in choroidal melanoma: Reversal of inverted CD4/CD8 ratios following treatment with ultrasonic hyperthermia. Biotechnol Ther 1994; 5: 59–68
   PubMedGoogle Scholar
• Wang X, Sun J. High-intensity focused ultrasound in patients with late-stage pancreatic carcinoma. Chin Med J (Engl) 2002; 115: 1332–1335
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Lu P, Xu ZL, Chen WZ, Zhu H, Jin CB. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med Biol 2004; 30: 1217–1222
   PubMed Web of Science ®Google Scholar
• Madersbacher S, Grobl M, Kramer G, Dirnhofer S, Steiner GE, Marberger M. Regulation of heat shock protein 27 expression of prostatic cells in response to heat treatment. Prostate 1998; 37: 174–181
   PubMed Web of Science ®Google Scholar
• Kramer G, Steiner GE, Grobl M, Hrachowitz K, Reithmayr F, Paucz L, Newman M, Madersbacher S, Gruber D, Susani M, et al. Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells. Prostate 2004; 58: 109–120
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Cao YD, Chen WZ, Zou JZ, Bai J, Zhu H. A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer. Br J Cancer 2003; 89: 2227–2233
   PubMed Web of Science ®Google Scholar
• Lepock JR, Frey HE, Ritchie KP. Protein denaturation in intact hepatocytes and isolated cellular organelles during heat shock. J Cell Biol 1993; 122: 1267–1276
   PubMed Web of Science ®Google Scholar
• Pockley AG. Heat shock proteins as regulators of the immune response. Lancet 2003; 362: 469–476
   PubMed Web of Science ®Google Scholar
• Todryk SM, Michael J, Goughy MJ, Pockley AG. Facets of heat shock protein 70 show immunotherapeutic potential. Immunology 2003; 110: 1–9
   PubMed Web of Science ®Google Scholar
• Li Z, Antoine Menoret A, Srivastava P. Roles of heat-shock proteins in antigen presentation and cross-presentation. Curr Opin Immunol 2002; 14: 45–51
   PubMed Web of Science ®Google Scholar
• Lewis JJ. Therapeutic cancer vaccines: Using unique antigens. PNAS 2004; 101(Suppl. 2)14653–14656
   PubMedGoogle Scholar
• Schueller G, Kettenbach J, Sedivy R, Bergmeister H, Stift A, Fried J, Gnant M, Lammer J. Expression of heat shock proteins in human hepatocellular carcinoma after radiofrequency ablation in an animal model. Oncol Reports 2004; 12: 495–499
   PubMed Web of Science ®Google Scholar